Bipolar disorder is officially classified as a psychiatric condition, not a neurological disorder. Both the DSM-5 and the World Health Organization’s ICD-11 place it under mood disorders, specifically in a chapter called “Bipolar or Related Disorders.” But this clean distinction is increasingly hard to defend on biological grounds. Decades of brain imaging, genetic research, and postmortem studies reveal that bipolar disorder involves measurable changes in brain structure, chemistry, and cellular function that overlap significantly with what we see in recognized neurological conditions.
Why It’s Classified as Psychiatric
The traditional dividing line between neurology and psychiatry comes down to one rule: if a disorder is reliably associated with a recognizable physical process affecting the central nervous system, it’s neurological. If it primarily shows up in thoughts, perceptions, moods, and behaviors without an obvious structural lesion, it falls to psychiatry. Bipolar disorder lands on the psychiatric side because there’s no single brain scan, blood test, or biopsy that can diagnose it. Diagnosis still depends on observing patterns of mood episodes, specifically mania and depression, over time.
That said, many researchers and clinicians now view the neurology-psychiatry boundary as a relic rather than a meaningful scientific distinction. The brain processes behind bipolar disorder are becoming clearer with every study, and they look remarkably similar to processes involved in conditions no one hesitates to call neurological.
What’s Happening in the Brain
Brain imaging studies show real structural differences in people with bipolar disorder. The largest longitudinal MRI study on the condition, involving over 1,200 individuals tracked by the ENIGMA consortium, found that people with bipolar disorder have faster enlargement of the brain’s fluid-filled ventricles compared to healthy controls. More telling, people who experienced frequent manic episodes showed accelerated thinning of the prefrontal cortex, the region most responsible for impulse control, planning, and emotional regulation.
Functional imaging tells a complementary story. The brain’s “fronto-limbic” network, which connects the prefrontal cortex to deeper emotional centers like the amygdala and hippocampus, shows reduced connectivity in bipolar disorder. Normally, the prefrontal cortex acts as a brake on emotional responses. In bipolar disorder, that brake is weakened. Inhibitory structures in the frontal lobe are underactive, while the amygdala, hippocampus, and parts of the temporal cortex run hotter than they should. This imbalance helps explain both the emotional intensity of mania and the difficulty regulating mood during depressive episodes.
The Role of Dopamine
Bipolar disorder’s two poles, mania and depression, appear to involve opposite ends of the same chemical seesaw. During mania, the brain’s reward-processing network becomes hyperactive. Imaging studies show elevated availability of certain dopamine receptors in the striatum, a deep brain region tied to motivation and pleasure. More available receptors mean more dopamine signaling, which drives the euphoria, impulsivity, and heightened energy characteristic of manic episodes.
During bipolar depression, the picture flips. Dopamine transporter levels rise in the striatum, meaning the brain is pulling dopamine out of the gap between neurons faster than usual. The result is reduced dopamine signaling, which maps onto the low motivation, flat mood, and loss of pleasure that define depressive episodes. Lithium, one of the oldest and most effective treatments for bipolar disorder, works in part by acting on intracellular signaling pathways downstream of dopamine receptors, essentially recalibrating the system from the inside.
Genetics Point to the Brain
Bipolar disorder is one of the most heritable psychiatric conditions. Twin studies estimate heritability between 60% and 90%, meaning genetics account for the majority of who develops it. Family-based studies put the number at around 44%, and the gap between these figures reflects different methodologies rather than genuine disagreement about the role of genes.
The largest genome-wide study, analyzing over 40,000 cases and 350,000 controls, identified 64 independent locations across the genome associated with bipolar disorder. One of the strongest associations involves a gene called CACNA1C, which codes for a calcium channel found in neurons. Calcium channels are fundamental to how brain cells fire and communicate. This is the same type of molecular machinery implicated in epilepsy and other conditions firmly in neurology’s territory. Other implicated regions include genes in the major histocompatibility complex, a set of immune-related genes also strongly linked to schizophrenia.
Bipolar I, characterized by full manic episodes, is more heritable than bipolar II, which involves milder hypomanic episodes. SNP-based heritability for bipolar I is roughly 25%, compared to 11% for bipolar II, suggesting a stronger genetic “loading” in the more severe form.
Circadian Clock Disruption
One of the most distinctive biological fingerprints of bipolar disorder involves the body’s internal clock. Several genes that regulate circadian rhythms, the 24-hour cycles governing sleep, hormone release, and body temperature, are disrupted in people with the condition. Mutations in the CLOCK gene, for instance, double the recurrence rate of bipolar episodes in people who carry two copies of a specific variant. In animal studies, mice with CLOCK gene mutations display behavior strikingly similar to mania: hyperactivity and reduced need for sleep. Lithium reversed many of these behaviors.
Other clock genes show similar patterns. Mutations in PER3 are linked to bipolar onset, treatment response, and daily mood fluctuations. CRY2 mutations are specifically associated with rapid cycling, the pattern of four or more mood episodes per year. BMAL1 mutations connect to fragmented sleep and weakened sleep-wake cycles. Together, these findings suggest that a fundamental timing mechanism in the brain is wired differently in people with bipolar disorder, and that this vulnerability sets the stage for mood episodes when the clock is thrown off by stress, travel, shift work, or sleep loss.
Inflammation Inside the Brain
Postmortem brain studies have found elevated levels of inflammatory markers in specific brain regions of people who had bipolar disorder. In the hippocampus, a region central to memory and emotional processing, levels of several inflammatory proteins were significantly higher compared to controls. Cortisol, the body’s primary stress hormone, was also elevated in the hippocampus, roughly five times higher than in people without the disorder.
People with bipolar disorder also show elevated levels of inflammatory markers in their blood, including proteins like IL-6 and TNF-alpha that are associated with systemic inflammation. This may help explain why bipolar disorder so frequently co-occurs with metabolic conditions like diabetes, obesity, and cardiovascular disease. The inflammation isn’t confined to the brain; it appears to be a whole-body process with particularly damaging effects on neural tissue.
Overlap With Neurological Conditions
Bipolar disorder shares striking biological features with epilepsy, a condition universally classified as neurological. Both involve episodic disruptions in brain activity. Both respond to some of the same medications, particularly anticonvulsants that stabilize ion channels and dampen abnormal electrical signaling. The “kindling” model, originally developed to explain how seizures become more frequent and severe over time, has been applied to bipolar disorder to explain why mood episodes can become more frequent and harder to treat without early intervention.
At the cellular level, both conditions involve disruptions in second-messenger systems, the internal relay networks that translate signals arriving at a neuron’s surface into action inside the cell. Changes in calcium signaling, protein kinase C activity, and G-protein function have been documented in both epilepsy and bipolar disorder. There is also evidence that mitochondrial dysfunction, meaning impaired energy production within brain cells, plays a role. Brain imaging using magnetic resonance spectroscopy has shown decreased cellular pH and abnormal energy metabolism in bipolar patients, suggesting that neurons aren’t producing or managing energy normally.
A Disorder That Defies Categories
The honest answer to whether bipolar disorder is neurological is that the question itself is becoming outdated. Bipolar disorder involves measurable brain changes, identifiable genetic variants affecting neural function, disrupted neurotransmitter systems, clock gene mutations, neuroinflammation, and mitochondrial problems. By any biological measure, it is a disorder of the brain. It remains classified as psychiatric largely because of how medicine organized itself historically, not because the biology supports a clean separation. For practical purposes, this classification means that psychiatrists, not neurologists, diagnose and treat it, and that the primary tools remain mood stabilizers, psychotherapy, and lifestyle management rather than the surgical or device-based interventions common in neurology.